HSD3B1 and prostate cancer: This study confirmed the finding that HSD3B1 genetic variation may be associated with detrimental outcomes of ADT on prognosis in Japanese men with prostate cancer, augmenting the robustness of previous findings and suggesting universal significance among different ethnicities.